Table 5 Comparison of dMMR immunophenotypes and MSI PCR status in the cancer cohort
dMMR | All (n) | Classic | Non-classic | Unusual |
|---|---|---|---|---|
all cancers (n) | 207 | 103 | 55 | 49 |
MSS/MSI-L | 124 | 42 (40.8%) | 36 (65.5%) | 46 (93.9%) |
MSI-H | 83 | 61 (59.2%) | 19 (34.5%) | 3 (6.1%) |
colorectal (n) | 157 | 75 | 43 | 39 |
MSS/MSI-L | 92 | 28 (37.3%) | 27 (62.8%) | 37 (94.9%) |
MSI-H | 65 | 47 (62.7%) | 16 (37.2%) | 2 (5.1%) |
non-colorectal (n) | 50 | 28 | 12 | 10 |
MSS/MSI-L | 32 | 14 (50.0%) | 9 (75.0%) | 9 (90.0%) |
MSI-H | 18 | 14 (50.0%) | 3 (25.0%) | 1 (10.0%) |